Raw data - Biomarker matrix to track short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer's disease
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Research data
应用场景：
创建时间：
2020-05-15
相关数据集
Table_2_Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment.xlsx
Mild cognitive impairment (MCI) is a transition between normal cognition (NC) and Alzheimer’s disease (AD). Differences in cortical thickness (ΔCT) have been reported in cases that degenerate from MCI
NIAID Data Ecosystem140
Table_2_The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology.DOCX
Dementia affects millions of individuals worldwide, yet there are no effective treatments. Alzheimer’s disease, the most common form of dementia, is characterized by amyloid and tau pathology with amy
NIAID Data Ecosystem50
Association of top hits with additional phenotypes of interest.
Results of association with respective plasma analytes, CSF analytes levels in samples with low AB42 (evidence of amyloid deposition), those with high AB42 (no evidence of deposition) is shown for eac
Figshare2015-12-02 更新30
Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature review
Alzheimer’s disease (AD) is the most common cause of dementia and is characterized by aggregation of amyloid and tau proteins in the brain. Results from genetic studies suggest that the pathophysiolog
NIAID Data Ecosystem50
Additional file 4 of Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progression
Additional file 4. Table S4: P values for the regression lines between the β values of the 10 CpG probes and the gene expression of PM20D1.
Figshare2024-02-14 更新40
